About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 443 record(s)
Req # A-2023-000423
Adverse Drug Reaction (ADR) for VEKLURY. Report number: 001036412.Organization: Health Canada
July 2023
Req # A-2023-000436
Adverse Drug Reactions (ADRs). Report numbers: 001022086, 001030141, 001027287, 001027289.Organization: Health Canada
July 2023
Req # A-2023-000499
Adverse Drug Reactions (ADRs). Report numbers: 001041172, 001041389, 001042026, 001042044.Organization: Health Canada
July 2023
Nothing to report this month
Organization: Canadian Northern Economic Development Agency
Req # A-2016-001921
All records as it pertains to Natural Product Number (NPN) 80043184 (Dove Cleartone)Organization: Health Canada
July 2022
Req # A-2017-001094
All documents from October 1, 2017 to November 16, 2017 that mention a tax on sugar or fat, a fat tax, a sugar tax, a sugar-sweetened beverage tax (SSB tax), soft drink tax, soda tax, or junk food taxOrganization: Health Canada
July 2022
Req # A-2017-001792
The most recent Drug Establishment Licence for Auro Pharma including any annexes listing foreign buildings and the drugs they are licensed to produce.Organization: Health Canada
July 2022
Req # A-2018-000383
All reviewers' reports regarding the cleared Supplement to a New Drug Submission (SNDS) for the pre-filled syringe presentation.Organization: Health Canada
July 2022
Req # A-2018-000944
All documents describing any and all features of the "class exemption" issued by the Minister of Health under s. 56 of the Controlled Drugs and Substances.Organization: Health Canada
July 2022
Req # A-2018-000999
All correspondence sent by Health Canada to Teva Pharmaceuticals USA between January 1, 1996 to January 1, 1998, with respect to the new drug submission for glatiramer acetate (tradename: COPAXONE, NDS 044430, rec. 1996-07-12), Notice of Compliance…Organization: Health Canada
July 2022